Qurient is a leading R&D based clinical stage biotechnology company in Korea, listed in KOSDAQ (118150). Main focus is on first-in-class small molecule therapeutics in oncology and inflammation TA. Qurient is a virtual company doing most of its R&D work through a wide range of international network, now seeking talents to bring the company to the next level.
All new recruits will be eligible for stock option plan to grow with the company
Qurient will consider candidates from academic background with passion for building career in the business development profession.
Chief Medical Officer
Part-time CMO based in the U.S. is acceptable.